|
IFNAR1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.559200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.735710E-02 |
| Normal-vs-Stage2 |
6.559000E-01 |
| Normal-vs-Stage3 |
4.366800E-01 |
| Normal-vs-Stage4 |
4.468500E-02 |
| Stage1-vs-Stage2 |
3.744200E-01 |
| Stage1-vs-Stage3 |
9.196200E-04 |
| Stage1-vs-Stage4 |
1.82197999999412E-05 |
| Stage2-vs-Stage3 |
3.521800E-01 |
| Stage2-vs-Stage4 |
8.482300E-02 |
| Stage3-vs-Stage4 |
2.038000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.228600E-01 |
| Normal-vs-AfricanAmerican |
4.140800E-01 |
| Normal-vs-Asian |
8.514000E-01 |
| Caucasian-vs-AfricanAmerican |
8.037900E-02 |
| Caucasian-vs-Asian |
6.792000E-01 |
| AfricanAmerican-vs-Asian |
8.455400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.336200E-01 |
| Normal-vs-Female |
2.119600E-01 |
| Male-vs-Female |
2.365200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.220600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.338210E-01 |
| Normal-vs-Age(61-80Yrs) |
9.982600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.472600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.458000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.294600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.413200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.553800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.741200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.554800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.237900E-03 |
| Normal-vs-Grade 2 |
8.260800E-03 |
| Normal-vs-Grade 3 |
7.751800E-01 |
| Normal-vs-Grade 4 |
2.335800E-03 |
| Grade 1-vs-Grade 2 |
1.667830E-01 |
| Grade 1-vs-Grade 3 |
1.895180E-03 |
| Grade 1-vs-Grade 4 |
1.26899999997043E-06 |
| Grade 2-vs-Grade 3 |
4.355300E-04 |
| Grade 2-vs-Grade 4 |
3.81809994731697E-09 |
| Grade 3-vs-Grade 4 |
2.280800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.956710E-04 |
| Normal-vs-ccB subtype |
2.233600E-01 |
| ccA subtype-vs-ccB subtype |
4.48929999841141E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.034800E-01 |
| Normal-vs-N1 |
3.431800E-01 |
| N0-vs-N1 |
3.004400E-01 |
|
|
